The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2020 2
2019 3
2016 1

Journal Article 7

1 - 7 of 7 Results

Refine Results

Refine Results:

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination

CITE Title : Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination Personal Author(s) : Shing, Jaimie Z.;Hull, Pamela C.;Zhu, Yuwei;Gargano, Julia W.;Markowitz, Lauri E.;Cleveland, Angela A.;Pemmaraju, Manideepthi;Park, Ina U.;Whitney, Erin;Mitchel, Edward F.;Griffin, Marie R.; Published Date : April 10 2019 Source : Papillomavirus Res. 2019; 7:141-149 URL : https://stacks.cdc.gov/view/cdc/78193 Shing, Jaimie Z. et al. (2019). Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination. 7 Shing, Jaimie Z. et al. "Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination" 7 (2019) Shing, Jaimie Z. et al. "Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination" vol. 7, 2019 Export RIS Citation Information.

:

Shing, Jaimie Z. ;

Hull, Pamela C.

April 10 2019 | Papillomavirus Res. 2019; 7:141-149

:

IntroductionEvidence of human papillomavirus (HPV) vaccine impact on anogenital warts (AGWs) by race or urbanicity in the US is lacking. We evaluated ...
Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria

CITE Title : Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria Personal Author(s) : Nowak, Rebecca G.;Gravitt, Patti E.;He, Xin;Ketende, Sosthenes;Anom, Wuese;Omuh, Helen;Blattner, William A.;Charurat, Manhattan E.; Published Date : 4 2016;4-2016; Source : Sex Transm Dis. 43(4):243-248 URL : https://stacks.cdc.gov/view/cdc/38434 Nowak, Rebecca G. et al. (2016). Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria. 43(4). Nowak, Rebecca G. et al. "Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria" 43, no. 4 (2016) Nowak, Rebecca G. et al. "Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria" vol. 43, no. 4, 2016 Export RIS Citation Information.

:

Nowak, Rebecca G. ;

Gravitt, Patti E.

4 2016 | Sex Transm Dis. 43(4):243-248

:

BackgroundPrevalence estimates of anal high-risk human papillomavirus (HR-HPV) are needed in sub-Saharan Africa where HIV is endemic. This study evalu...
Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018

CITE Title : Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018 Personal Author(s) : Meites, Elissa;Winer, Rachel L.;Newcomb, Michael E.;Gorbach, Pamina M.;Querec, Troy D.;Rudd, Jessica;Collins, Tom;Lin, John;Moore, Janell;Remble, Thomas;Swanson, Fred;Franz, Justin;Bolan, Robert K.;Golden, Matthew R.;Mustanski, Brian;Crosby, Richard A.;Unger, Elizabeth R.;Markowitz, Lauri E.; Published Date : 6 06 2020 Source : J Infect Dis. 222(12):2052-2060 URL : https://stacks.cdc.gov/view/cdc/97468 Meites, Elissa et al. (2020). Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018. 222(12). Meites, Elissa et al. "Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018" 222, no. 12 (2020) Meites, Elissa et al. "Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018" vol. 222, no. 12, 2020 Export RIS Citation Information.

:

Meites, Elissa ;

Winer, Rachel L.

6 06 2020 | J Infect Dis. 222(12):2052-2060

:

Background.In the United States, human papillomavirus (HPV) vaccination has been recommended for young adult men who have sex with men (MSM) since 201...
Determinants of Type-Specific HPV Concordance Across Anatomic Sites in Young Men Who Have Sex with Men and Transgender Women, 3 U.S. Cities, 2016–2018

CITE Title : Determinants of Type-Specific HPV Concordance Across Anatomic Sites in Young Men Who Have Sex with Men and Transgender Women, 3 U.S. Cities, 2016–2018 Personal Author(s) : Shah, Adeel;Meites, Elissa;Lin, John;Hughes, James P.;Gorbach, Pamina M.;Mustanski, Brian;Crosby, Richard A.;Unger, Elizabeth R.;Querec, Troy;Golden, Matthew;Markowitz, Lauri E.;Winer, Rachel L.; Published Date : 4 01 2024;4-01-; Source : Sex Transm Dis. 51(4):260-269 URL : https://stacks.cdc.gov/view/cdc/153602 Shah, Adeel et al. (2024). Determinants of Type-Specific HPV Concordance Across Anatomic Sites in Young Men Who Have Sex with Men and Transgender Women, 3 U.S. Cities, 2016–2018. 51(4). Shah, Adeel et al. "Determinants of Type-Specific HPV Concordance Across Anatomic Sites in Young Men Who Have Sex with Men and Transgender Women, 3 U.S. Cities, 2016–2018" 51, no. 4 (2024) Shah, Adeel et al. "Determinants of Type-Specific HPV Concordance Across Anatomic Sites in Young Men Who Have Sex with Men and Transgender Women, 3 U.S. Cities, 2016–2018" vol. 51, no. 4, 2024 Export RIS Citation Information.

:

Shah, Adeel ;

Meites, Elissa

4 01 2024 | Sex Transm Dis. 51(4):260-269

:

Background:Among men who have sex with men (MSM) and transgender women (TGW), the dynamics of HPV infections at different anatomical sites are not wel...
A diagnostic evaluation of a molecular assay used for testing and treating anorectal chlamydia and gonorrhoea infections at the point-of-care in Papua New Guinea

CITE Title : A diagnostic evaluation of a molecular assay used for testing and treating anorectal chlamydia and gonorrhoea infections at the point-of-care in Papua New Guinea Personal Author(s) : Badman, S.G.;Willie, B.;Narokobi, R.;Gabuzzi, J.;Pekon, S.;Amos-Kuma, A.;Hakim, A.J.;Weikum, D.;Gare, J.;Silim, S.;Guy, R.J.;Donovan, B.;Cunningham, P.;Kaldor, J.M.;Vallely, A.J.;Whiley, D.;Kelly-Hanku, A.; Published Date : 5 2019 Source : Clin Microbiol Infect. 25(5):623-627 URL : https://stacks.cdc.gov/view/cdc/154164 Badman, S.G. et al. (2019). A diagnostic evaluation of a molecular assay used for testing and treating anorectal chlamydia and gonorrhoea infections at the point-of-care in Papua New Guinea. 25(5). Badman, S.G. et al. "A diagnostic evaluation of a molecular assay used for testing and treating anorectal chlamydia and gonorrhoea infections at the point-of-care in Papua New Guinea" 25, no. 5 (2019) Badman, S.G. et al. "A diagnostic evaluation of a molecular assay used for testing and treating anorectal chlamydia and gonorrhoea infections at the point-of-care in Papua New Guinea" vol. 25, no. 5, 2019 Export RIS Citation Information.

:

Badman, S.G. ;

Willie, B.

5 2019 | Clin Microbiol Infect. 25(5):623-627

:

Objectives:Papua New Guinea has among the highest prevalences of sexually transmissible infections (STIs) globally with no services able to accurately...
Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study

CITE Title : Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study Personal Author(s) : Patel, Pragna;Bush, Tim;Conley, Lois;Unger, Elizabeth R.;Darragh, Teresa M.;Henry, Keith;Escota, Gerome;Brooks, John T.;Kojic, Erna Milunka; Published Date : 6 29 2020;6-29-; Source : J Infect Dis. 222(2):234-242 URL : https://stacks.cdc.gov/view/cdc/168749 Patel, Pragna et al. (2020). Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study. 222(2). Patel, Pragna et al. "Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study" 222, no. 2 (2020) Patel, Pragna et al. "Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study" vol. 222, no. 2, 2020 Export RIS Citation Information.

:

Patel, Pragna ;

Bush, Tim

6 29 2020 | J Infect Dis. 222(2):234-242

:

Background.High-risk anal human papillomavirus (HPV) infection is prevalent among men living with human immunodeficiency virus (HIV); the association ...
Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics—Sexually Transmitted Disease Surveillance Network, United States, 2010–2016

CITE Title : Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics—Sexually Transmitted Disease Surveillance Network, United States, 2010–2016 Personal Author(s) : Mann, Laura M.;Llata, Eloisa;Flagg, Elaine W.;Hong, Jaeyoung;Asbel, Lenore;Carlos-Henderson, Juli;Kerani, Roxanne P.;Kohn, Robert;Pathela, Preeti;Schumacher, Christina;Torrone, Elizabeth A.; Published Date : 4 16 2019;4-16-; Source : J Infect Dis. 219(9):1389-1397 URL : https://stacks.cdc.gov/view/cdc/83574 Mann, Laura M. et al. (2019). Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics—Sexually Transmitted Disease Surveillance Network, United States, 2010–2016. 219(9). Mann, Laura M. et al. "Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics—Sexually Transmitted Disease Surveillance Network, United States, 2010–2016" 219, no. 9 (2019) Mann, Laura M. et al. "Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics—Sexually Transmitted Disease Surveillance Network, United States, 2010–2016" vol. 219, no. 9, 2019 Export RIS Citation Information.

:

Mann, Laura M. ;

Llata, Eloisa

4 16 2019 | J Infect Dis. 219(9):1389-1397

:

Background.Approximately 90% of genital warts are caused by human papillomavirus (HPV) types 6 and 11. In the United States, HPV vaccination has been ...